Log in

Login to your account

Username
Password *
Remember Me

TBnet PUBLICATIONS


Year

Publication

... Pubmed link   Journal link = free full text

2016

 

 

 

 

 

 

 

 

2015

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2014

Blauenfeldt T, Wagner D, Aabye M, Heyckendorf J, Lange B, Lange C, Ernst M, Ravn P, Duarte R, Morais C, Hoffmann M, Schoch O, Dominguez J, Latorre I, Ruhwald M. Thermostability of IFN-γ and IP-10 release assays for latent infection with Mycobacterium tuberculosis: A TBNET study. Tuberculosis 2015 (in press)


Lange C, van Leth F, Sester M, for the TBnet. Viral load and risk of tuberculosis in HIV-infection J Acquir Immune Defic Syndr. 2016 Feb 1;71(2):e51-3. doi: 10.1097/QAI.0000000000000834.


Domínguez J, Boettger EC, Cirillo D, Cobelens F,Eisenach KD, Gagneux S, Hillemann D, Horsburgh R, Molina-Moya B, Niemann S, Tortoli E,Whitelaw A, Lange C for the TBNET and RESIST-TB networks. Clinical implications of molecular drug resistance testing for M. tuberculosis: a TBNET/RESIST-TB consensus statement Int J Tuberc Lung Dis. 2016 Jan;20(1):24-42. doi: 10.5588/ijtld.15.0221.


Dierig A, Tebruegge M, Krivec U, Heininger U, Ritz N; Paediatric Tuberculosis  Network European Trials group (ptbnet). Current status of Bacille Calmette Guérin (BCG) immunisation in Europe - A ptbnet survey and review of current guidelines.  Vaccine. 2015 Sep 11;33(38):4994-9. doi: 10.1016/j.vaccine.2015.06.097. Epub 2015 Jul 4. PubMed PMID: 26151543. 


Günther G, Gomez GB, Lange C, Rupert S, van Leth F; on behalf of the TBNET. Availability, price and affordability of anti-tuberculosis drugs in Europe: A TBNET surveyEur Respir J.2014 Nov 13. pii: erj01246-2014. [Epub ahead of print]


Ritz N, Brinkmann F, Garcia BS, Tebruegge M, Kampmann B; Paediatric Tuberculosis Network European Trials group (ptbnet). Tuberculosis in young refugees. Lancet. 2015 Dec 19;386(10012):2475-6. doi: 10.1016/S0140-6736(15)01241-6. Epub 2015 Dec 18. PubMed PMID: 26738710. 


Sester M, van Crevel R, Leth Fv, Lange C. Numbers needed to treat to prevent tuberculosis. Eur Respir J. 2015 Dec;46(6):1836-8. doi: 10.1183/13993003.01047-2015. PubMed PMID: 26621887.


Zellweger JP, Sotgiu G, Block M, Dore S, Altet N, Blunschi R, Bogyi M, Bothamley G, Bothe C, Codecasa L, Costa P, Dominguez J, Duarte R, Fløe A, Fresard I, García-García JM, Goletti D, Halm P, Hellwig D, Henninger E, Heykes-Uden H, Horn L, Kruczak K, Latorre I, Pache G, Rath H, Ringshausen FC, Seminario Ruiz A, Solovic I, de Souza-Galvão ML, Widmer U, Witte P, Lange C; TBNET; Risk Assessment of Tuberculosis in Contacts by Interferon-γ Release Assays (IGRAs). A TBNET Study. PMID: 25763458, AJRCCM 2015

 


 

Sester M, van Leth F, Bruchfeld J, Bumbacea D, Cirillo DM, Gorek Dilektasli A, Domínguez J, Duarte R, Ernst M, Oner Eyuboglu F, Gerogianni I, Girardi E, Goletti D, Janssens JP, Julander I, Lange B, Latorre I, Losi M, Markova R, Matteelli A, Milburn H, Ravn P, Scholman T, Soccal PM, Straub M, Wagner D, Wolf T, Yalcin A, Lange C; for the TBNET. Risk Assessment of Tuberculosis in Immunocompromised Patients - A TBNET Study, Am J Respir Crit Care Med. 2014 Oct 10. [Epub ahead of print], PMID: 25303140 [PubMed - as supplied by publisher]


Christoph Lange, Ibrahim Abubakar, Jan-Willem C. Alffenaar, Graham Bothamley, Jose A. Caminero, Anna Cristina C. Carvalho, Kwok-Chiu Chang, Luigi Codecasa, Ana Correia, Valeriu Crudu, Peter Davies, Martin Dedicoat, Francis Drobniewski, Raquel Duarte, Cordula Ehlers, Connie Erkens, Delia Goletti, Gunar Günther, Elmira Ibraim, Beate Kampmann, Liga Kuksa, Wiel de Lange, Frank van Leth, Jan van Lunzen, Alberto Matteelli, Dick Menzies, Ignacio Monedero, Elvira Richter, Sabine Ru¨sch-Gerdes, Andreas Sandgren, Anna Scardigli, Alena Skrahina, Enrico Tortoli, Grigory Volchenkov, Dirk Wagner, Marieke J. van der Werf, Bhanu Williams, Wing-Wai Yew, Jean-Pierre Zellweger and Daniela Maria Cirillo for the TBNET; Management of patients with multidrugresistant/ extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement, ERJ 2014


 

 

 

 

 

 

 

Pubmed

 

 

 

Pubmed

 

Pubmed

 

 

Pubmed

 

 

 

 

 

Pubmed

 

 

 

 

Pubmed

 

 

 

 

Pubmed

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

ERJ

2013
Hoefsloot W, van Ingen J, Andrejak C, Angeby K, Bauriaud R, Bemer P, Beylis N, Boeree MJ, Cacho J, Chihota V, Chimara E, Churchyard G, Cias R, Dasa R, Daley CL, Dekhuijzen PN, Domingo D, Drobniewski F, Esteban J, Fauville-Dufaux M, Folkvardsen DB, Gibbons N, Gómez-Mampaso E, Gonzalez R, Hoffmann H, Hsueh PR, Indra A, Jagielski T, Jamieson F, Jankovic M, Jong E, Keane J, Koh WJ, Lange B, Leao S, Macedo R, Mannsåker T, Marras TK, Maugein J, Milburn HJ, Mlinkó T, Morcillo N, Morimoto K, Papaventsis D, Palenque E, Paez-Peña M, Piersimoni C, Polanová M, Rastogi N, Richter E, Ruiz-Serrano MJ, Silva A, da Silva MP, Simsek H, van Soolingen D, Szabó N, Thomson R, Fernandez MT, Tortoli E, Totten SE, Tyrrell G, Vasankari T, Villar M, Walkiewicz R, Winthrop K, Wagner D; for NTM-NET (www.ntm-net.org).
The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: A NTM-NET collaborative study. ERJ 2013
  Pubmed    
 

Tebruegge M, Salo E, Ritz N, Kampmann B, On Behalf Of The Paediatric Tuberculosis Network European Trialsgroup ptbnet. Inclusion of latent tuberculosis infection as a separate entity into the international classification of diseases.  Thorax. 2013 Jun; 68(6):588. doi: 10.1136/thoraxjnl-2012-202824


  Pubmed    
2012

Giovanni Sotgiu, Lia D’Ambrosio, Rosella Centis, Graham Bothamley, Daniela M. Cirillo, Saverio De Lorenzo, Gunar Guenther, Kai Kliiman, Ralf Muetterlein, Victor Spinu, Miguel Villar, Jean-Pierre Zellweger, Andreas Sandgren, Emma Huitric, Christoph Lange, Davide Manissero and Giovanni Battista Migliori. Availability of anti-tuberculosis drugs in Europe. Eur Respir J. 2012


  Pubmed   ERJ
 

Rasu Roy R, Sotgui G, Altet-Gomez N, Tsolia M, Ruga E, Velizarova S, Kampmann B. Identifying predictors of interferon-gamma release assay results in pediatric latent tuberculosis: a protective role of BCG? A PTBNET collaborative study. Am J Respir Crit Care Med 2012


  Pubmed   Am J Respr Crit Care Med
 

Bumbacea D, Arend SM, Eyuboglu F, Fishman JA; GolettiD, Ison MG, Jones CE, Kampmann B, Kotton CN, Lange C, Ljungman P; Milburn H; Morris MI; Muller E; Muñoz P, Nellore A, Rieder HL, Sester U, Theodoropoulos N, Wagner D, Sester M. The risk of tuberculosis in transplant candidates and recipients: A TBNET consensus statement. Eur Respir J. 2012


Giehl C, Lange C, Duarte R, Bothamley G, Gerlach C, Cirillo DM, Wagner D, Kampmann B, Goletti D, Juers T, Sester M., TBNET - Collaborative research on tuberculosis in Europe, Eur J Microbiol Immunol (Bp). 2012 Dec;2(4):264-74. doi: 10.1556/EuJMI.2.2012.4.4. Epub 2012 Dec 11.


 

Pubmed

 

 

Pubmed

 

 

 

 

 

  Migliori GB, Sotgiu G, D’Ambrosio L, Centis R, Lange C, Bothamley G, Cirillo DM, De Lorenzo S, Guenther G, Kliiman K, Muetterlein R, Spinu V, Villar M, Zellweger JP, Sandgren A, Huitric E, Manissero D. TB and MDR/XDR-TB in the EU and EEA/EFTA countries: managed or mismanaged? Eur Respir J. 2012
  Pubmed    
           
2011

Diel R, Goletti D, Ferrara G, Bothamley G, Cirillo D, Kampmann B, Lange C, Losi M, Markova R, Migliori GB, Nienhaus A, Ruhwald M, Wagner D, Zellweger JP, Huitric E, Sandgren A, Manissero D. Interferon-g release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. Eur Respir J. 2011;37(1):88-99.


  Pubmed
  ERJ

 

Sester M, Sotgiu G, Lange C, Giehl C, Girardi E, Migliori GB, Bossink A, Dheda K, Diel R, Dominguez J, Lipman M, Nemeth J, Ravn P, Winkler S, Huitric E, Sandgren A, Manissero D. Interferon-g release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis. Eur Respir J. 2011; 37(1):100-11.


  Pubmed   ERJ

 

Lange C, Sester M, Sotgiu G, Giehl C, Girardi E, Bossink A, Dheda K, Diel R, Dominguez J, Lipman M, Migliori GB, Nemeth J, Ravn P, Winkler S, Huitric E, Sandgren A, Manissero D. Interferon- release assays for diagnosis of active pleural tuberculosis: a developing world perspective. Eur. Respir. J. 2011 38: 747-748.


  Pubmed
  ERJ

 

Lange C, Rieder H, Sester M, Milburn H, Kampmann B, Migliori GB, Solovic I. Diagnosis of tuberculosis in patients with psoriasis: the need for a modified approach. Eur. Respir. J. 2011 38: 232-233.


  Pubmed   ERJ

  Ruhwald M, Dominguez J, Latorre I, Losi M, Richeldi L, Pasticci MB, Mazzolla R, Goletti D, Butera O, Bruchfeld J, Gaines H, Gerogianni I, Tuuminen T, Ferrara G, Eugen-Olsen J, Ravn P; TBNET. A multicentre evaluation of the accuracy and performance of IP-10 for the diagnosis of infection with M. tuberculosis. Tuberculosis (Edinb). 2011; 91(3):260-7.

Sotgiu G, D'AmbrosioL, Centis R, Bothamley G, Cirillo DM, De Lorenzo S, Guenther G, Kliiman K, Muetterlein R, Spinu V, Villar M, Zellweger JP, Sandgren A, Huitric E, Lange C, Manissero D, Migliori GB.  TB and M/XDRTB infection control in European TB centres:  the Achilles’ heel?   Eur Respir J. 2011 Nov; 38(5):1221-3. doi: 10.1183/09031936.00029311.


Migliori GB, Sotgiu G, Lange C, Centis R.  Extensively drug-resistant tuberculosis: back to the future.  Eur Respir J. 2010 Sep; 36(3):475-7. doi: 10.1183/09031936.00025910.

 

Pubmed

 

 

Pubmed

 

 

Pubmed

  Link
 
       
2010

Solovic I, Sester M, Gomez-Reino JJ, Rieder HL, Ehlers S, Milburn HJ, Kampmann B, Hellmich B, Groves R, Schreiber S, Wallis RS, Sotgiu G, Schövinck EH, Goletti D, Zellweger JP, Diel R, Carmona L, Bartalesi F, Ravn P, Bossink A, Duarte R, Erkens C, Clark J, Migliori GB, Lange C. The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement. Eur Respir J. 2010;36(5):1185-206.


  Pubmed
  ERJ

  Sotgiu G, Centis R, D'ambrosio L, De Lorenzo S, D'arcy Richardson M, Lange C, Manissero D, Migliori GB; TBNET MDR-TB project. Development of a standardised tool to survey MDR-/XDR-TB case management in Europe. Eur Respir J. 2010; 36(1):208-11.
  Pubmed
  ERJ

  Sotgiu G, Centis R, Lange C, D'Ambrosio L, Guenther G, Spanevello A, Migliori GB. Safety of linezolid in MDR-/XDR-TB treatment: is there any difference in India and Europe?. Eur. Respir. J. 2010 35: 938-940.
  Pubmed
  ERJ

  Lange C, Bossink A, Eberhardt R, Goletti D, Jafari C, Latorre I, Kirsten D, Losi M, Migliori GB, Sotgiu G. Bronchoalveolar lavage immunodiagnosis for tuberculosis suspects in Europe and Africa. Thorax. 2010 Sep;65(9):842; author reply 842-3.
  Pubmed
  Link
  Erkens CG, Kamphorst M, Abubakar I, Bothamley GH, Chemtob D, Haas W, Migliori GB, Rieder HL, Zellweger JP, Lange C. Tuberculosis contact investigation in low prevalence countries: a European consensus. Eur Respir J. 2010; 36(4):925-49.
  Pubmed
  ERJ

           
2009 Mack U, Migliori GB, Sester M, Rieder HL, Ehlers S, Goletti D, Bossink A, Magdorf K, Hölscher C, Kampmann B, Arend SM, Detjen A, Bothamley G, Zellweger JP, Milburn H, Diel R, Ravn P, Cobelens F, Cardona PJ, Kan B, Solovic I, Duarte R, Cirillo DM; C. Lange; TBNET. LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur Respir J. 2009; 33(5):956-73.
  Pubmed
  ERJ

  Bamford AR, Crook AM, Clark JE, Nademi Z, Dixon G, Paton JY, Riddell A, Drobniewski F, Riordan A, Anderson ST, Williams A, Walters S, Kampmann B. Comparison of interferon-gamma release assays and tuberculin skin test in predicting active tuberculosis (TB) in children in the UK: a paediatric TB network study. Arch Dis Child. 2010;95(3):180-6.
  Pubmed

  ADC
  Migliori GB, D'Arcy Richardson M, Sotgiu G, Lange C. Multidrug-resistant and extensively drug-resistant tuberculosis in the West. Europe and United States: epidemiology, surveillance, and control. Clin Chest Med. 2009;30:637-65
  Pubmed   Link
  Jafari C, Thijsen S, Sotgiu G, Goletti D, Domínguez Benítez JA, Losi M, Eberhardt R, Kirsten D, Kalsdorf B, Bossink A, Latorre I, Migliori GB, Strassburg A, Winteroll S, Greinert U, Richeldi L, Ernst M, Lange C; Tuberculosis Network European Trialsgroup. Bronchoalveolar lavage enzyme-linked immunospot for a rapid diagnosis of tuberculosis: a Tuberculosis Network European Trialsgroup study. Am J Respir Crit Care Med. 2009;180(7):666-73.
  Pubmed
  AJRCCM
  Migliori GB, Eker B, Richardson MD, Sotgiu G, Zellweger JP, Skrahina A, Ortmann J, Girardi E, Hoffmann H, Besozzi G, Bevilacqua N, Kirsten D, Centis R, Lange C; TBNET Study Group. A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis. Eur Respir J. 2009; 34(2):387-93.
  Pubmed
  ERJ

  Sotgiu G, Ferrara G, Matteelli A, Richardson MD, Centis R, Ruesch-Gerdes S, Toungoussova O, Zellweger JP, Spanevello A, Cirillo D, Lange C, Migliori GB. Epidemiology and clinical management of XDR-TB: a systematic review by TBNET. Eur Respir J. 2009; 33(4):871-81.
  Pubmed
  ERJ

  Migliori GB, Sotgiu G, D'Arcy Richardson M, Centis R, Facchini A, Guenther G, Spanevello A, Lange C; TBNET. MDR-TB and XDR-TB: drug resistance and treatment outcomes. Eur Respir J. 2009; 34(3):778-9.
  Pubmed
  ERJ

  Sotgiu G, Lange C, Richardson MD, Matteelli A, Centis R, Eker B, Guenther G, Spanevello A, Migliori GB; TBNET. Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis. J Antimicrob Chemother. 2009;64(4):879-83.
  Pubmed

  JAC

  Migliori GB, Sotgiu G, D'Arcy Richardson M, Centis R, Guenther G, Hoffmann H, Cirillo DM, Toungossova O, Kliiman K, De Lorenzo S, Spanevello A, Lange C; Tuberculosis Network European Trialsgroup. Consensus not yet reached on key drugs for extensively drug-resistant tuberculosis treatment. Clin Infect Dis. 2009 15;49(2):315-6
  Pubmed
  CID

           
2008 Migliori GB, Lange C, Girardi E, Centis R, Besozzi G, Kliiman K, Ortmann J, Matteelli A, Spanevello A, Cirillo DM; SMIRA/TBNET Study Group. Extensively drug-resistant tuberculosis is worse than multidrug-resistant tuberculosis: different methodology and settings, same results. Clin Infect Dis. 2008 15;46(6):958-9.
  Pubmed
  CID

  Migliori GB, Lange C, Girardi E, Centis R, Besozzi G, Kliiman K, Codecasa LR, Spanevello A, Cirillo DM; SMIRA/TBNET Study Group. Fluoroquinolones: are they essential to treat multidrug-resistant tuberculosis? Eur Respir J. 2008;31(4):904-5.
  Pubmed   ERJ

  Migliori GB, Lange C, Centis R, Sotgiu G, Mütterlein R, Hoffmann H, Kliiman K, De Iaco G, Lauria FN, Richardson MD, Spanevello A, Cirillo DM; TBNET Study Group. Resistance to second-line injectables and treatment outcomes in multidrug-resistant and extensively drug-resistant tuberculosis cases. Eur Respir J. 2008; 31(6):1155-9.
  Pubmed
  ERJ


  Bothamley GH, Ditiu L, Migliori GB, Lange C; TBNET contributors. Active case finding of tuberculosis in Europe: a Tuberculosis Network European Trials Group (TBNET) survey. Eur Respir J. 2008; 32(4):1023-30.
  Pubmed   ERJ

  Ruhwald M, Bodmer T, Maier C, Jepsen M, Haaland MB, Eugen-Olsen J, Ravn P; TBNET. Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis. Eur Respir J. 2008; 32(6):1607-15.
  Pubmed   ERJ

  Eker B, Ortmann J, Migliori GB, Sotgiu G, Muetterlein R, Centis R, Hoffmann H, Kirsten D, Schaberg T, Ruesch-Gerdes S, Lange C; German TBNET Group. Multidrug-and extensively drug-resistant tuberculosis, Germany. Emerg Infect Dis. 2008; 14(11):1700-6.
  Pubmed   EID

  Goletti D, Carrara S, Butera O, Amicosante M, Ernst M, Sauzullo I, Vullo V, Cirillo D, Borroni E, Markova R, Drenska R, Dominguez J, Latorre I, Angeletti C, Navarra A, Petrosillo N, Lauria FN, Ippolito G, Migliori GB, Lange C, Girardi E. Accuracy of immunodiagnostic tests for active tuberculosis using single and combined results: a multicenter TBNET-Study. PLoS One. 2008; 3(10):e3417.
  Pubmed
  PLoSONE

           
2007 Losi M, Bossink A, Codecasa L, Jafari C, Ernst M, Thijsen S, Cirillo D, Ferrarese M, Greinert U, Fabbri LM, Richeldi L, Lange C; European Tuberculosis Network TBNET. Use of a T-cell interferon-gamma release assay for the diagnosis of tuberculous pleurisy. Eur Respir J. 2007;30(6):1173-9.
  Pubmed   ERJ


  Migliori GB, Ortmann J, Girardi E, Besozzi G, Lange C, Cirillo DM, Ferrarese M, De Iaco G, Gori A, Raviglione MC; SMIRA/TBNET Study Group. Extensively drug-resistant tuberculosis, Italy and Germany. Emerg Infect Dis. 2007;13(5):780-2.
  Pubmed   EID

  Migliori GB, Besozzi G, Girardi E, Kliiman K, Lange C, Toungoussova OS, Ferrara G, Cirillo DM, Gori A, Matteelli A, Spanevello A, Codecasa LR, Raviglione MC; SMIRA/TBNET Study Group. Clinical and operational value of the extensively drug-resistant tuberculosis definition. Eur Respir J. 2007; 30(4):623-6.   Pubmed   ERJ